Filing Date | 
					T Date | 
					Ticker | 
										Sector | 
					Ind | Industry |  
						Owner | 
						oSt | 
						Rel | 
						Title | 
					 
					T | 
					TVal | 
					Price | 
					L | 
					Qty | 
					oc | 
					Own | 
					H | 
					r2y | 
					r1y | 
					r6m | 
					r3m | 
					r6w | 
					r3w | 
					r7d | 
					r3d | 
					f1d | 
					f1w | 
					f1m | 
					f3m | 
					f6m | 
					f1y | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/12/14 17:01  | 3/7/14  | CBRX | Health | Drug | Pharmaceutical Preparations | Actavis Plc | NJ | T | S.a | -8,509 | 6.08 | 0 | -1,400 | -100 | 0 | I | |||||||||||||||
3/11/14 17:12  | 3/7/14  | CBRX | Health | Drug | Pharmaceutical Preparations | Actavis Plc | NJ | T | S | -8,064 | 5.76 | 0 | -1,400 | -100 | 0 | I | |||||||||||||||
2/21/07 16:27  | 2/15/07  | CBRX | Health | Drug | Pharmaceutical Preparations | Curran John P | NY | T | S.m | -454 | 1.40 | 3 | -324 | -6 | 4,871 | I | -29 | -69 | -55 | -68 | -70 | -69 | 1 | 7 | -1 | -5 | -6 | 63 | 53 | 52 | |
2/7/07 12:00  | 2/5/07  | CBRX | Health | Drug | Pharmaceutical Preparations | Knott David M | NY | T | S.d | -1,994 | 1.42 | 4 | -1,400 | -38 | 2,318 | I | -31 | -70 | -52 | -65 | -73 | -68 | -67 | -68 | -3 | -8 | -17 | 73 | 55 | 36 | |
6/6/06 16:34  | 6/5/06  | CBRX | Health | Drug | Pharmaceutical Preparations | Blechschmidt Edward A | CA | D | S.m | -75 | 4.18 | 1 | -18 | -24 | 56 | b | -4 | -13 | -8 | -27 | 7 | -41 | |||||||||
10/3/05 16:54  | 9/30/05  | CBRX | Health | Drug | Pharmaceutical Preparations | Blechschmidt Edward A | CA | D | S.m | -75 | 3.73 | 0 | -20 | -24 | 64 | I | -66 | 24 | 93 | 23 | 42 | 24 | 17 | 16 | 10 | -2 | -6 | 15 | 24 | -15 | |
8/19/03 16:25  | 8/19/03  | COB | Health | Drug | Pharmaceutical Preparations | Mills Robert S | CT | O | SVP - Op | S.d | -829 | 13.27 | 0 | -63 | -100 | 0 | D | 27 | -14 | -1 | -9 | 5 | -1 | 1 | 0 | 12 | -12 | -16 | -31 | ||
8/12/03 11:37  | 8/11/03  | COB | Health | Drug | Pharmaceutical Preparations | Oskowitz Selwyn P | MA | D | S.d | -430 | 12.28 | 0 | -35 | -100 | 0 | D | 24 | -20 | 1 | -13 | -13 | -2 | 5 | 4 | 11 | -3 | -8 | -28 | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |